___

• 1. Wheeldon NM, Mac Donald TM, Flucker CJ, et al.: Echocardiography in chronic heart failure in the community. O J Med 1993; 86:17-23. 2. Clarkson PBM, Wheeldon NM, MacLeod C, et al.: Effect of angiotensin IIand aldosterone on diastolic function in vivo in normal man. Clin Sci 1994; 87:397-401 3. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the ACE gene accounting for half of the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346. 4. Zee RYL, Solomon SD, Ajani UA, Pfeffer MA, Lindpaintner K. A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the ‘Healing and Early Afterload Reducing Therapy’ Study. Clin Genet 2002; 61:21-25. 5. Wang JG, Staessen JA. Genetic polymorphisms in the renin-anjiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacology 2000; 410:289-302. 6. Chesebro JH, Knatterud G, Roberts R, et al.: Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987; 76:142-154. 7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497. 8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2571. 9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus : Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22:5-19. 10. Miller SA, Dykes DD, Polesky HF. A simple saltig out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215. 11. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20:1433. 12. Heyndrickx GR, Paulus WJ: Effect of asynchrony on left ventricular relaxation. Circulation 1990; 81:41. 13. Hess OM, Osakada G, Lavelle JF, et al: Diastolic myocardial wall stiffness and ventricular relaxation during partial and complete coronary occlusions in the conscious dog. Circ Res 1983; 52:387. 14. Neyses L, Vetter H: Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease. J Hypertens 1990; 8:99-102. 15. Alderman EL, Glantz SA: Acute hemodynamic interventions shift the diastolic pressure-volume curve in man. Circulation 1976; 54:662-761. 16. Haber HL, Powers ER, Gimple LW, et al. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 1994; 89:2606-2615. 17. Friedrich SP, Lorell BH, Rousseau MF, et al.: Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994; 90:2761-2771. 18. Ledru F, Blanchard D, Battaglia S, et al.: Relation Between Severity of Coronary Artery Disease, Left Ventricular Function, and Myocardial Infarction, and Influence of the ACE I/D Gene Polymorphism. Am J Cardiol 1998; 82:160-165 19. Isbir T, Yilmaz H, Agachan B, Aydin M, Isbir CS. Association between angiotensinconverting enzyme gene polymorphism and coronary artery disease. IUBMB Life. 1999; 48:205-207. 20. Akar N, Aras O, Omurlu K, Cin S. Deletion polymorphism at the angiotensinconverting enzyme gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest. 1998; 58:491-495. 21. Tokgozoglu SL, Alikasifoglu M, Atalar E, et al. Angiotensin converting enzyme gene polymorphism and the risk and extent of ischemic heart disease among Turkish patients. Coron Artery Dis. 1997;8:137-141. 22. Clarkson PBM, Prasad N, Macleod C et al.:Influence of the angiotensin converting enzyme I/D gene polymorphisms on left ventricular diastolic filling in patients with essential hypertension. J.Hypertens 1997; 15:995-1000. 23. He Y, Tomita Y, Kusama Y, et al. A role of angiotensin-converting enzyme gene polymorphism in left ventricular remodeling after myocardial infarction.] J Nippon Med Sch 200; 67:96-104. 24. Nagashima J, Musha H, So T, et al. Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction. Clin Cardiol 1999; 22:587-590. 25. Nacak M, Davutoğlu V, Soydinç S et al. Association Between Angiotensin Converting Enzyme Gene Polymorphism and Coronary Artery Disease in Individuals of the South-Eastern Anatolian Population. Anadolu Kardiyol Derg 2004; 4:19-22. 26. Danser AHJ, Schalekamp MADH, Bax WA et al. Angotensin-Converting Enzyme in the Human Heart. Circulation 1995; 92:1387- 1388.